JuvTherapeutics is developing traditional prescription medicines that help modify aging and prevent diseases. With a team of world-class drug developers and scientists in partnership with us, we’re targeting the fundamental molecular, cellular, and tissue pathways of aging.
How do we do that? By identifying pharmacotherapies of great potential and managing their development to maximize the chance and speed of regulatory approval.
Working with a team of scientists, we’re targeting the fundamental molecular, cellular, and tissue pathways of aging by identifying pharmacotherapies of great potential and managing their development.
Our focus is on organ regeneration and the unlimited regenerative capacity of cells. We are making strategic investments and building a team at the forefront of the science of human aging.
Artificial intelligence and machine learning will drive incredible efficiency and effectiveness in drug development. This is a key competitive advantage in our pursuit of new therapies that confront aging.